Role of norepinephrine in the pathophysiology and treatment of mood disorders.
about
Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease PathogenesisNeurotransmitter transporters: fruitful targets for CNS drug discoveryAcute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis studyBrain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNAA preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorderNorepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome.Effects of overnight sleep restriction on brain chemistry and mood in women with unipolar depression and healthy controlsAssociation between depressive symptoms and fibrosis markers: the Cardiovascular Health Study.Effects of the G(-656)A variant on CREB1 promoter activity in a neuronal cell line: interactions with gonadal steroids and stressPresynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?Estimation of binding rate constants using a simultaneous mixed-effects method: application to monoamine transporter reuptake inhibitor reboxetineNeurohormonal and inflammatory hyper-responsiveness to acute mental stress in depressionDrugs in development for social anxiety disorder: more to social anxiety than meets the SSRI.Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders.[Physiopathology of bipolar disorders: what have changed in the last 10 years?].Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.Regulation of monoamine transporters: Role of transporter phosphorylation.Further evidence of association between amphetamine response and SLC6A2 gene variantsThere and back again: a tale of norepinephrine and drug addiction.Effects of the A(-115)G variant on CREB1 promoter activity in two brain cell lines: Interactions with gonadal steroids.Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future.Are multiple physical symptoms a poor prognostic factor or just a marker of depression severity? Secondary analysis of the GenPod trial.Serotonergic and noradrenergic function in depression: clinical correlatesElectrophysiological properties of catecholaminergic neurons in the norepinephrine-deficient mouseMonoamine transporters: vulnerable and vital doorkeepers.What is the impact of child abuse on gray matter abnormalities in individuals with major depressive disorder: a case control studyExpanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency.Serotonin-induced hypersensitivity via inhibition of catechol O-methyltransferase activityNo stress please! Mechanisms of stress hyporesponsiveness of the maternal brain.Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease.Increased plasma norepinephrine concentration in psychotic depressionSynthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.Change in Brainstem Gray Matter Concentration Following a Mindfulness-Based Intervention is Correlated with Improvement in Psychological Well-BeingMonoamine and neuropeptide-related function: prospects for novel therapeutics of depression.Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.Conotoxin therapeutics: a pipeline for success?Neurobiological correlates of social anxiety disorder: an update.Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis.Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors.Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.
P2860
Q27027221-DAB51B66-379C-45AD-B50C-10BE88F5C719Q28140501-2E87F99C-1EFB-4F39-93D2-EB273914A720Q28345792-991B59F8-89C7-4F73-A3CF-6DA176177B7EQ28361194-92843BDF-FD4F-4AD7-B966-F179DF7C5C26Q30498105-6AA66764-99C6-411F-89AF-5FE5D4187194Q33162642-2A68FFAF-CC2F-46FE-9F20-458A8BB71FE0Q33498962-2B454E03-F3D5-4B96-9878-4ED7A169FF39Q33637776-CE237568-1AEC-443A-8DE8-469E8733F20EQ33694233-C0220F03-C224-45BF-A48B-5B14151A5EC6Q33731267-F14D6DF7-6F59-44CC-B160-9922A0E699E0Q33870452-E5459480-1C44-4531-842B-4B14523D43EFQ33872507-3EFBC006-6019-450B-B130-30D7980D7392Q34075089-36D489AC-E127-46EC-9FC8-E93794A40937Q34146169-C28B2C41-D4F4-46B0-9C23-9A6B97F67FD2Q34376230-1A7B949C-4388-4365-BF71-17055AC6292FQ34395267-BCB323DC-BE76-4E06-A816-8EB9E52A794EQ34540543-496EE369-08F2-4639-9137-D44EAC361AEAQ34565939-10D4519D-EB9E-43F2-9505-E048B0877C18Q34590409-47AC05D3-5358-4AEA-8F5C-DB67190E653FQ34803025-EA6A2DB3-84E1-46FF-8FFF-5ED60A730F9DQ35040802-F6A403A4-A988-4937-BDB0-43692CE12958Q35044690-875C4E48-B589-4D05-9884-7CE218F9EB87Q35236257-91BC3150-F605-4DA6-B8EC-AA1C519B3B08Q35741014-4CB10A77-CFE3-4312-A4CF-B3020173E8C9Q35877150-C54708C4-D481-4233-B99A-0616AB38B790Q36192004-69DDF89B-9BBD-4260-A40C-CB41DF67B133Q36226255-F53E72F3-3CE3-4283-8A80-0B8373A8F5CFQ36391713-2D98C6F2-D095-45D0-97A8-499ADBE10867Q36987512-BDA6271C-67E6-4A3B-84A6-3B595AB56B73Q36998284-D083C3D8-45BB-4D0B-ACED-77F7CCEA4EA9Q37079024-75F3DF3C-7720-4FDA-9487-02B923A06364Q37352287-01331769-F3A8-43E6-A0F2-3126C16D6C6EQ37589856-F0718F00-4E11-4B9D-A7A7-B0FC4EE315B9Q37610277-DD918051-F568-466D-84A2-C6DFAE7816CCQ37706110-687D32BC-0032-4EF8-A034-C797CE6B1B57Q38088765-48A35214-1B3D-4AA4-984E-8CAE90384F33Q38191310-F341A5CC-0AA2-46F1-AE3E-50F671124C92Q38194251-A6831320-DD75-4287-AF9F-81188F4FB749Q38316708-240414ED-8B4C-4264-9793-B62026B86975Q38875190-FEFAFF76-9E30-432D-9947-9A758C945CC5
P2860
Role of norepinephrine in the pathophysiology and treatment of mood disorders.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Role of norepinephrine in the pathophysiology and treatment of mood disorders.
@ast
Role of norepinephrine in the pathophysiology and treatment of mood disorders.
@en
type
label
Role of norepinephrine in the pathophysiology and treatment of mood disorders.
@ast
Role of norepinephrine in the pathophysiology and treatment of mood disorders.
@en
prefLabel
Role of norepinephrine in the pathophysiology and treatment of mood disorders.
@ast
Role of norepinephrine in the pathophysiology and treatment of mood disorders.
@en
P1476
Role of norepinephrine in the pathophysiology and treatment of mood disorders.
@en
P2093
Nemeroff CB
P304
P356
10.1016/S0006-3223(99)00127-4
P407
P577
1999-11-01T00:00:00Z